CD44 and breast carcinoma: Moreover, basal‐like TNBCs are enriched in poorly differentiated breast cancer stem cells (BCSCs) with the CD44+/CD24− phenotype3 and the frequency of CD44+/CD24− BCSCs has been shown to be related to chemotherapy resistance of breast cancer.4, 5